Amylin Pharmaceuticals News

The source should read: Rheingold, Valet, Rheingold, McCartney & Giuffra LLP. Also, the client has advised us to the following changes: The first paragraph went out as "The law firm of Rheingold, Valet, Rheingold, McCartney & Giuffra LLP has just commenced what is believed to be the first suit in for the development of pancreatic cancer in the user ... (more)

Clovis Oncology, Inc. , announced today the addition of two new members to its Board of Directors, Ginger Graham and Keith Flaherty, M.D. "We are delighted to add these two gifted individuals to our Board of Directors as the Company matures into a later-stage developer of oncology products and ultimately a commercial organization," said Patrick J.

A former Bristol-Myers Squibb Co. executive has admitted to trading on confidential information ahead of the drug maker's acquisition of Amylin Pharmaceuticals Inc., according to the U.S. Attorney for the District of New Jersey.

The top 100 revenue-generating public biotech companies featured in this annual compilation garnered 2012 revenue of $113.34 billion versus $100.61 billion in the prior year, a 12.7 percent improvement.

It also provides disease prevention products, acute and chronic pain management products and insulin skin patches for diabetes.